Abstract
In the past decade, academic screening centers have been created in many universities worldwide. Most of these screening centers are organized as core facilities that accept projects from both within their organization and from external users in order to maximize staff and instrument usage. The Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany, also created such a screening facility named the Technology Development Studio (TDS). The mission of the facility is to provide cell based screening services focused on high resolution confocal imaging. The acquisition of high resolution images allows the mathematical description of cells with image analysis to a high degree of precision. This precision in turn allows classifying phenotypes accurately and compare different cellular treatments to discover underlying mechanisms.
Keywords: Chemical screening, complex biology, high content screening, multi parametric statistics, RNAi.
Combinatorial Chemistry & High Throughput Screening
Title:The Technology Development Studio of the MPI-CBG: An Open Access Cell-Based Screening Facility
Volume: 17 Issue: 4
Author(s): Marc Bickle
Affiliation:
Keywords: Chemical screening, complex biology, high content screening, multi parametric statistics, RNAi.
Abstract: In the past decade, academic screening centers have been created in many universities worldwide. Most of these screening centers are organized as core facilities that accept projects from both within their organization and from external users in order to maximize staff and instrument usage. The Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany, also created such a screening facility named the Technology Development Studio (TDS). The mission of the facility is to provide cell based screening services focused on high resolution confocal imaging. The acquisition of high resolution images allows the mathematical description of cells with image analysis to a high degree of precision. This precision in turn allows classifying phenotypes accurately and compare different cellular treatments to discover underlying mechanisms.
Export Options
About this article
Cite this article as:
Bickle Marc, The Technology Development Studio of the MPI-CBG: An Open Access Cell-Based Screening Facility, Combinatorial Chemistry & High Throughput Screening 2014; 17 (4) . https://dx.doi.org/10.2174/1386207317666140323133018
DOI https://dx.doi.org/10.2174/1386207317666140323133018 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes
Current Diabetes Reviews Small Heat Shock Proteins (sHSPs) As Potential Drug Targets
Current Pharmaceutical Biotechnology Nutrigenetics, Metabolic Syndrome Risk and Personalized Nutrition
Current Vascular Pharmacology Having a Promising Efficacy on Type II Diabetes, It’s Definitely a Green Tea Time
Current Medicinal Chemistry Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations
Current Genomics Opioid Receptor Ligands Derived from Food Proteins
Current Pharmaceutical Design Berberine: A Fluorescent Alkaloid with a Variety of Applications from Medicine to Chemistry
Mini-Reviews in Organic Chemistry Vasopressin in Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Mast Cells as a Double Edged Sword in Immunity: Disorders of Mast Cell Activation and Therapeutic Management. Second of Two Parts
Endocrine, Metabolic & Immune Disorders - Drug Targets WNT Signaling in Stem Cell Biology and Regenerative Medicine
Current Drug Targets Update on Alzheimer’s Disease Therapeutics
Reviews on Recent Clinical Trials Congenital Disorders of Glycosylation (CDG): Update and Perspectives
Current Pediatric Reviews Future Challenges for Microsomal Transport Protein Inhibitors
Current Vascular Pharmacology Use of Continuous Glucose Monitoring in Patients with Type 1 Diabetes
Current Diabetes Reviews Synthesis of 6-s-cis and 6-s-trans A-Ring Modified Vitamin D Analogues
Current Topics in Medicinal Chemistry Graphical Abstracts
Current Nanoscience The Fibroblast Growth Factor 23: A New Player in the Field of Cardiovascular, Bone and Renal Disease
Current Vascular Pharmacology Patent Selections
Recent Patents on Cardiovascular Drug Discovery Prevention and Treatment of Regimen-Related Mucosal Toxicity
Recent Patents on Anti-Cancer Drug Discovery Clinical Use and Patentability of Cord Blood
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)